Show simple item record

dc.contributor.authorBermejo, Almudena
dc.contributor.authorBarrachina, Isabel
dc.contributor.authorEl Aouad, Noureddine
dc.contributor.authorFranck, Xavier
dc.contributor.authorChahboune, Nadia
dc.contributor.authorAndreu, Inmaculada
dc.contributor.authorFigadère, Bruno
dc.contributor.authorVila, Laura
dc.contributor.authorhennuyer, Nathalie
dc.contributor.authorStaels, Bart
dc.contributor.authorDacquet, Catherine
dc.contributor.authorCaignard, Daniel H.
dc.contributor.authorSanz, María-Jesús
dc.contributor.authorCortés, Diego
dc.contributor.authorCabedo, Nuria
dc.identifier.citationBermejo, A., Barrachina, I., El Aouad, N., Franck, X., Chahboune, N., Andreu, I., ... & Dacquet, C. (2019). Synthesis of benzopyran derivatives as PPARα and/or PPARγ activators. Bioorganic & medicinal chemistry, 27(24), 115162.
dc.description.abstractWe describe the synthesis of 26 compounds, small polycerasoidol analogs, that are Lipinski’s rule-of-five compliant. In order to confirm key structural features to activate PPARα and/or PPARγ, we have adopted structural modifications in the following parts: (i) the benzopyran core (hydrophobic nucleus) by benzopyran-4-one, dihydrobenzopyran or benzopyran-4-ol; (ii) the side chain at 2-position by shortening to C3, C4 and C5-carbons versus C-9-carbons of polycerasoidol; (iii) the carboxylic group (polar head) by oxygenated groups (hydroxyl, acetoxy, epoxide, ester, aldehyde) or non-oxygenated motifs (allyl and alkyl). Benzopyran-4-ones 6, 12, 13 and 17 as well as dihydrobenzopyrans 22, 24 and 25 were able to activate hPPARα, whereas benzopyran-4-one (7) with C5-carbons in the side chain exhibited hPPARγ agonism. According to our previous docking studies, SAR confirm that the hydrophobic nucleus (benzopyran-4-one or dihydrobenzopyran) is essential to activate PPARα and/or PPARγ, and the flexible linker (side alkyl chain) should containg at least C5-carbon atoms to activate PPARγ. By contrast, the polar head (“carboxylic group”) tolerated several oxygenated groups but also non-oxygenated motifs. Taking into account these key structural features, small polycerasoidol analogs might provide potential active molecules useful in the treatment of dyslipidemia and/or type 2
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.subjectPPARα agonismes
dc.subjectPPARγ agonismes
dc.titleSynthesis of benzopyran derivatives as PPARα and/or PPARγ activatorses
dc.authorAddressInstituto Valenciano de Investigaciones Agrarias (IVIA), Carretera CV-315, Km. 10’7, 46113 Moncada (Valencia), Españaes
dc.entidadIVIACentro de Citricultura y Producción Vegetales
dc.journal.titleBioorganic & Medicinal Chemistryes
dc.subject.agrisF60 Plant physiology and biochemistryes

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 España
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 España